Recurrent Verrucous Carcinoma of the Larynx Completed Phase 1 Trials for 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (DB15243)

IndicationStatusPhase
DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00470496Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerTreatment